October 2020 in “International journal of Ayurvedic medicine” In this case study, a combination of leech therapy and Ayurvedic treatment led to complete hair regrowth in an 18-year-old female with alopecia areata after six weeks, suggesting potential benefits of these treatments for similar cases.
January 2020 in “International Research Journal of Ayurveda & Yoga” In this study, Ayurvedic treatment including Pracchan karma, Siro lepa, and Samana chikista over four months resolved symptoms of Alopecia Areata in a woman who maintained improvement one year post-treatment.
January 2020 in “Open University of Cape Town (University of Cape Town)” In this study, neonatal mouse mesenchymal cells showed hair-inducing capabilities, which were lost during in vitro propagation but could be partially restored through specific high-density culture methods.
January 2020 in “Elsevier eBooks” This review discusses the potential health benefits of Indian gooseberries, including blood glucose management and cardiovascular health, and highlights the need for additional research; no new clinical results are reported.
November 2019 in “Harper's Textbook of Pediatric Dermatology” This index of Harper's Textbook of Pediatric Dermatology, Fourth Edition, provides no clinical results or new findings.
November 2019 in “International journal of research in Ayurveda and pharmacy” In this case report, a 35-year-old male experiencing hair loss showed improvement with new hair growth after receiving Ayurvedic Rakta Mokshana therapy, including Pracchana and Cupping, within 15 days.
This handbook of dermatology provides a comprehensive practical manual for dermatologists, but reports no new research findings.
September 2019 in “Journal of Investigative Dermatology” This study found that using human induced pluripotent stem cells (iPSC) carrying the causal mutation of Epidermolysis Bullosa simplex provides a robust model for understanding its molecular mechanisms and testing potential therapeutic targets.
This book overview summarizes advances in integrative dermatology without presenting any new research findings.
January 2019 in “Industrial Law Journal” This article reviews two new legislative measures affecting domiciliary care workers in Wales and reports no new research results; it highlights implications for labor law and devolution debates.
This case study reported that Ayurvedic treatment using Pracchana and Bibhitaki Lepa significantly improved symptoms of alopecia areata in a 41-year-old woman, reducing patch size and hair fall.
This comprehensive index provides references and classification criteria for various medical conditions but offers no new research findings.
July 2018 in “International journal of research - granthaalayah” In this clinical trial, the authors observed that Dravanti beeja lepa may be safe and effective for promoting hair regrowth in patients with Indralupta (Alopecia Areata).
July 2018 in “Zenodo (CERN European Organization for Nuclear Research)” In this study, the use of Dravanti beeja lepa for 28 days was observed to significantly regenerate hair in patients with Indralupta (Alopecia Areata).
The document's conclusion cannot be determined as the content is not available.
This study concluded that medieval Āyurvēda's treatment of Indralupta aligns with modern understanding of androgenic alopecia, emphasizing the historical scientific basis of Āyurvēda.
July 2017 in “Journal of Ayurveda and Integrated Medical Sciences” This study reported that Ayurvedic treatment involving the internal administration of Vidangarishta, Krimikutararasa, and Shatavari Guda, alongside external papaya exudate application, led to significant, rapid, and lasting improvements in alopecia areata in a week-long trial.
May 2017 in “The journal of investigative dermatology/Journal of investigative dermatology” In this study, researchers found potential evidence of inducible skin-associated lymphoid tissue (iSALT) in alopecia areata patients undergoing topical immunotherapy, which may suggest an essential role in treatment efficacy.
April 2017 in “Journal of Pharmaceutical Investigation” In this study, the administration of indole-based compounds, particularly L-Tryptophan and Tryptophol, to a PCOS-induced rat model resulted in an increased number of healthy ovarian follicles and a reduction in ovarian cysts compared to untreated rats, suggesting potential therapeutic efficacy.
February 2017 in “Spectrum Research Repository (Concordia University)” This study confirmed porcine PRP's commercial viability as a fetal bovine serum replacement, showing higher growth factor levels and stability, without increasing human follicle dermal papilla cell proliferation compared to FBS.
January 2017 in “Enlighten: Publications (The University of Glasgow)” This study found that in mice with deregulated β-catenin and PTEN signaling, increased follicular hyperplasia and sebaceous gland changes occur, but typical papillomas do not develop, potentially due to p21 response and reduced stem cell markers.
This article is a reference guide to skin conditions and syndromes, providing no new research findings but covering clinical features, diagnosis, pathogenesis, and treatments.
This study found that human hair follicles can be used to generate induced pluripotent stem cells, which can then efficiently differentiate back into keratinocytes.
November 2016 in “Therapeutic Delivery” New drugs for Alzheimer's and rheumatoid arthritis advanced, a Zika vaccine is in development, and there were business deals in anesthesia and oncology.
September 2016 in “Journal of Dermatological Science” This study found that extracellular factors from a specific developmental stage can promote hair follicle neogenesis in adult skin by facilitating interactions between fibroblasts and keratinocytes.
September 2016 in “Journal of Dermatological Science” This study found that protein extracts from embryonic skin can induce hair follicle neogenesis in mice by activating insulin/IGF signaling in adult fibroblasts.
This article serves as an index for various dermatological conditions and treatments, but reports no new research findings.
June 2016 in “Indian Journal of Pharmacy Practice” This report suggests that fluvoxamine use may be associated with hair loss, as observed in a 28-year-old male whose condition improved after stopping the drug.
I cannot provide a conclusion without the content of the document.